Atropa 0.6 MG Injection 1 ML

Atropa 0.6 MG Injection 1 ML is used for the following:

• Managing an abnormally slow heart rhythm

• Emergency treatment during cardiac arrest

• Reducing excessive secretions before surgery

• Counteracting organophosphate insecticide poisoning

• Reversing the effects of neuromuscular blocking agents

• Treating carbamate pesticide poisoning

• Managing excessive salivation during procedures

• Decreasing bronchial secretions in surgical settings

• Restoring normal cardiac function in emergencies

• Supporting heart rate during specific medical interventions

Follow these instructions when Atropa 0.6 MG Injection 1 ML is administered:

• This medicine must only be administered by qualified healthcare professionals.

• Ensure the injection site is properly cleaned before administration.

• When administered intravenously, the medicine should be given slowly.

• Proper aseptic technique must be used to prevent infection.

• The medicine should remain in its original packaging until ready for use.

Atropa 0.6 MG Injection 1 ML is administered intravenously, intramuscularly, or subcutaneously.

Atropa 0.6 MG Injection 1 ML contains atropine (0.6 mg), which works on the body as follows:

• Muscarinic receptor blockade: Atropine competitively blocks muscarinic acetylcholine receptors throughout your body, preventing the neurotransmitter acetylcholine from binding to these receptors.

• Heart rate regulation: By blocking the vagal influence on the sinoatrial node (your heart's natural pacemaker), atropine increases heart rate, which helps manage bradycardia (abnormally slow heart rhythm).

• Secretion reduction: It inhibits the production of secretions in various glands, including those in your airways and digestive tract, leading to a drier mouth and respiratory passages.

• Smooth muscle relaxation: Atropine relaxes smooth muscles in various organs, including those in the gastrointestinal tract, urinary bladder, and airways.

• Store Atropa 0.6 MG Injection 1 ML at room temperature below 30°C.

• Keep the injection protected from light in its original packaging.

• Avoid freezing the injection as this can damage the solution.

• Store away from excessive heat and moisture.

• Keep out of reach of children.

• Do not use after the expiry date printed on the packaging.

• If you have been prescribed Atropa 0.6 MG Injection 1 ML for managing bradycardia (abnormally slow heart rate), moderate physical activity like walking can help improve overall heart health when your condition stabilises.

• Avoid excessive caffeine intake, as it may interfere with your heart rhythm or interact with other medications or treatments.